Dr. Bernardo Goulart

For the Media

Dr. Bernardo Goulart

Dr. Bernardo Goulart is a member of Fred Hutch's Clinical Research and Public Health Sciences divisions.  He is a faculty member of the Hutchinson Institute for Cancer Outcomes Research (HICOR). He analyzes large databases to identify the impact of treatment practices on patient outcomes.

Resources for more information

  • Overview of Bernardo Goulart's Research
    Comparative effectiveness analysis; cost effectiveness analysis, health economics, cancer outcomes research.
  • Bernard Goulart - Curriculum Vitae
    Appointment and affiliations
  • Bernardo Goulart's SCCA profile
    Dr. Goulart treats patients for lung cancer and head and neck cancers. He is also board certified in Internal Medicine.
  • HICOR
    Hutchinson Institute for Cancer Outcomes Research (HICOR) is a research institute at Fred Hutch whose mission is to improve cancer prevention, detection and treatment in ways that will reduce the economic and human burden of cancer—ultimately leading to better outcomes for patients.
  • Public Health Sciences Division
    Using large populations as our laboratory, our researchers look for links between cancer and its possible triggers, from diet and lifestyle to environmental and genetic factors.
  • Clinical Research Division
    Researchers conduct laboratory and patient-oriented research to better understand the mechanisms that drive cancer and other human diseases. Integrating a variety of disciplines, our investigators are continually developing new therapeutic approaches and leading clinical trials that help move discoveries from laboratory to patient. Our pioneering research has saved hundreds of thousands of lives.

FOR THE MEDIA

Hutch Team

For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.


 

Photos / Graphics / Video

Download

Download photos and view video of Bernardo Goulart

Related Stories


At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.